LimFlow System Demonstrates Excellent Sustained Amputation-free Survival and Wound Healing at 1 Year in PROMISE I U.S. Study
LimFlow notes the results were presented in the Late-Breaking Data session at the VIVA Conference by Daniel Clair, MD, PROMISE I principal investigator and chair of the department of surgery at the University of South Carolina (USC) and Prisma Health-USC Medical Group.